HER2.M+ Trademark

Trademark Overview


On Monday, January 20, 2025, a trademark application was filed for HER2.M+ with the United States Patent and Trademark Office. The USPTO has given the HER2.M+ trademark a serial number of 99012962. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 28, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The HER2.M+ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of medical research information and scientific information in the field of oncology
her2.m+

General Information


Serial Number99012962
Word MarkHER2.M+
Filing DateMonday, January 20, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkHER TO M PLUS
Pseudo MarkHER TWO M PLUS
Goods and ServicesProvision of medical research information and scientific information in the field of oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE

Trademark Events


Event DateEvent Description
Monday, January 20, 2025NEW APPLICATION ENTERED
Monday, January 20, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, June 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 30, 2025ASSIGNED TO EXAMINER
Monday, July 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 28, 2025NON-FINAL ACTION E-MAILED
Monday, July 28, 2025NON-FINAL ACTION WRITTEN